Mnc Pharma

Jump to

Pharma market to sustain growth in FY15-16: P Lilladher

According to Prabhudas Lilladhe, The Indian Pharma market (IPM) growth is expected to sustain in FY15E-16E.
See Sensex beyond 21000 by year-end: Angel Broking

Rajen Shah of Angel Broking is extremely positive on the market and sees the Sensex crossing 21,000 mark by this year end.
Compulsory license forces MNC pharma to rework India plan

Compulsory license granted to Natco has left the Indian pharma industry with a hard choice to make - cut prices, or quit selling the drug. To counter this drug-makers are changing strategies, reports CNBC-TV18's Archana Shukla.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Mnc Pharma

Pharma market to sustain growth in FY15-16: P Lilladher

See Sensex beyond 21000 by year-end: Angel Broking

Compulsory license forces MNC pharma to rework India plan